Immune checkpoint protein VISTA can directly turn off T-cells during immunotherapy, study finds

FHS
May 17, 2024
6:23 pm

A Cleveland Clinic-led team of scientists and physicians have discovered that the immune checkpoint protein VISTA can directly turn off tumor-fighting T-cells during immunotherapy and resist treatment.

BioCina and NovaCina forge strategic alliance to offer biologics developers integrated drug substance and drug product solutions

BioCina Pty Ltd., a global end-to-end biologics Contract Development and Manufacturing Organisation (CDMO), and NovaCina Pty Ltd., a global fill-and-finish CDMO, announced a strategic partnership

February 29, 2024

How Special Olympics kickstarted the push for better disability data

On July 1st, 1995, the world’s spotlight shone upon Yale’s football stadium in New Haven, Connecticut. It was the latest Special Olympics World Games, and

September 25, 2024

Roche to take on Abbott, Dexcom with its first CGM

Listen to the article 5 min This audio is auto-generated. Please let us know if you have feedback. Dive Brief: Roche shared details of its

March 7, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.